In addition, we observed that CD93 has a key role in tumor vascular maturation and extracellular matrix organization and is a potential therapeutic target, and a previous study showed that CD93 regulates Integrin β signaling activation and fibronectin fibril organization during tumor angiogenesis (57). The gene discussed is FN1; the disease is neoplasm.